Psyence Biomedical Ltd.
Pharmaceutical company · Toronto, Ontario, Canada · Nasdaq: PBM
Psyence Biomedical Ltd. is a pharmaceutical company headquartered in Toronto, Ontario, Canada. Its earliest recorded incorporation is in 2023. Its shares trade on Nasdaq under the ticker PBM. It has reported private securities offerings to the US SEC, most recently $2 million sold in a notice filed in 2025.
Psyence Biomedical at a glance
What does Psyence Biomedical do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $2 million sold (2025).
Frequently asked questions about Psyence Biomedical
Where is Psyence Biomedical headquartered?
Psyence Biomedical Ltd. is headquartered in Toronto, Ontario, Canada.
What does Psyence Biomedical do?
Psyence Biomedical Ltd. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Psyence Biomedical a public company?
Yes. Psyence Biomedical Ltd. trades on Nasdaq under the ticker PBM.
When was Psyence Biomedical founded?
The earliest incorporation on record for Psyence Biomedical Ltd. is in 2023, according to public company registers.
Similar companies
- Medicenna Therapeutics Corp.Toronto, Ontario, Canada
- ProMIS Neurosciences Inc.Toronto, Ontario, Canada
- Quantum Biopharma Ltd.Toronto, Ontario, Canada
- Intellipharmaceutics International Inc.Toronto, Ontario, Canada
- Avicanna Inc.Toronto, Ontario, Canada
- Bradmer Pharmaceuticals IncToronto, Ontario, Canada
- Organigram Global Inc.Toronto, Ontario, Canada
- Sunovion CNS Development Canada UlcToronto, Ontario, Canada
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences